Literature DB >> 24690678

Through the looking glass: an exploratory study of the lived experiences and unmet needs of families affected by Von Hippel-Lindau disease.

Nadine A Kasparian1, Alison Rutstein2, Ursula M Sansom-Daly1, Shab Mireskandari1, Janet Tyler3, Jessica Duffy3, Katherine M Tucker3.   

Abstract

Despite well-established protocols for the medical management of Von Hippel-Lindau disease (VHL), families affected by this rare tumour syndrome continue to face numerous psychological, social, and practical challenges. To our knowledge, this is one of the first qualitative studies to explore the psychosocial difficulties experienced by families affected by VHL. A semi-structured interview was developed to explore patients' and carers' experiences of VHL along several life domains, including: self-identity and self-esteem, interpersonal relationships, education and career opportunities, family communication, physical health and emotional well-being, and supportive care needs. Quantitative measures were also used to examine the prevalence of anxiety, depression, and disease-specific distress in this sample. Participants were recruited via the Hereditary Cancer Clinic at the Prince of Wales Hospital in Sydney, Australia. A total of 23 individual telephone interviews were conducted (15 patients, 8 carers), yielding a response rate of 75%. A diverse range of experiences were reported, including: sustained uncertainty about future tumour development, frustration regarding the need for lifelong medical screening, strained family relationships, difficulties communicating with others about VHL, perceived social isolation and limited career opportunities, financial and care-giving burdens, complex decisions in relation to childbearing, and difficulties accessing expert medical and psychosocial care. Participants also provided examples of psychological growth and resilience, and voiced support for continued efforts to improve supportive care services. More sophisticated systems for connecting VHL patients and their families with holistic, empathic, and person-centred medical and psychosocial care are urgently needed.

Entities:  

Mesh:

Year:  2014        PMID: 24690678      PMCID: PMC4266731          DOI: 10.1038/ejhg.2014.44

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  27 in total

1.  Can a "prompt list" empower cancer patients to ask relevant questions?

Authors:  Aneta Dimoska; Martin H N Tattersall; Phyllis N Butow; Heather Shepherd; Paul Kinnersley
Journal:  Cancer       Date:  2008-07-15       Impact factor: 6.860

Review 2.  A review of psychosocial interventions for children with chronic health conditions.

Authors:  L J Bauman; D Drotar; J M Leventhal; E C Perrin; I B Pless
Journal:  Pediatrics       Date:  1997-08       Impact factor: 7.124

3.  Unpacking the blockers: understanding perceptions and social constraints of health communication in hereditary breast ovarian cancer (HBOC) susceptibility families.

Authors:  June A Peters; Regina Kenen; Lindsey M Hoskins; Laura M Koehly; Barry Graubard; Jennifer T Loud; Mark H Greene
Journal:  J Genet Couns       Date:  2011-05-06       Impact factor: 2.537

Review 4.  Caring for the carers: quality of life in Huntington's disease.

Authors:  Aimee Aubeeluck
Journal:  Br J Nurs       Date:  2005 Apr 28-May 11

5.  Psychosocial impact of Von Hippel-Lindau disease: levels and sources of distress.

Authors:  C R M Lammens; E M A Bleiker; S Verhoef; F J Hes; M G E M Ausems; D Majoor-Krakauer; R H Sijmons; R B van der Luijt; A M W van den Ouweland; T A M Van Os; N Hoogerbrugge; E B Gómez García; C J Dommering; C M Gundy; N K Aaronson
Journal:  Clin Genet       Date:  2010-02-11       Impact factor: 4.438

Review 6.  Cancer and caregiving: the impact on the caregiver's health.

Authors:  C Nijboer; R Tempelaar; R Sanderman; M Triemstra; R J Spruijt; G A van den Bos
Journal:  Psychooncology       Date:  1998 Jan-Feb       Impact factor: 3.894

Review 7.  von Hippel-Lindau disease.

Authors:  V Couch; N M Lindor; P S Karnes; V V Michels
Journal:  Mayo Clin Proc       Date:  2000-03       Impact factor: 7.616

8.  Von Hippel-Lindau disease: a genetic study.

Authors:  E R Maher; L Iselius; J R Yates; M Littler; C Benjamin; R Harris; J Sampson; A Williams; M A Ferguson-Smith; N Morton
Journal:  J Med Genet       Date:  1991-07       Impact factor: 6.318

Review 9.  von Hippel-Lindau disease.

Authors:  Russell R Lonser; Gladys M Glenn; McClellan Walther; Emily Y Chew; Steven K Libutti; W Marston Linehan; Edward H Oldfield
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

10.  Uptake of genetic testing and long-term tumor surveillance in von Hippel-Lindau disease.

Authors:  Astrid Rasmussen; Elisa Alonso; Adriana Ochoa; Irene De Biase; Itziar Familiar; Petra Yescas; Ana-Luisa Sosa; Yaneth Rodríguez; Mireya Chávez; Marisol López-López; Sanjay I Bidichandani
Journal:  BMC Med Genet       Date:  2010-01-12       Impact factor: 2.103

View more
  7 in total

1.  Minors at risk of von Hippel-Lindau disease: 10 years' experience of predictive genetic testing and follow-up adherence.

Authors:  Roseline Vibert; Khadija Lahlou-Laforêt; Maryam Samadi; Valérie Krivosic; Thomas Blanc; Laurence Amar; Nelly Burnichon; Caroline Abadie; Stéphane Richard; Anne-Paule Gimenez-Roqueplo
Journal:  Eur J Hum Genet       Date:  2022-08-02       Impact factor: 5.351

2.  Disclosure of genetic risk to dating partners among young adults with von Hippel-Lindau disease.

Authors:  Elysa Bond; Beverly Yashar; Tobias Else; Jenae Osborne; Monica Marvin
Journal:  Fam Cancer       Date:  2022-08-19       Impact factor: 2.446

3.  A Novel von Hippel Lindau Gene Intronic Variant and Its Reclassification from VUS to Pathogenic: the Impact on a Large Family.

Authors:  A Sexton; L Rawlings; G McKavanagh; K Simons; I Winship
Journal:  J Genet Couns       Date:  2015-09-02       Impact factor: 2.537

4.  "Getting ready for the adult world": how adults with spinal muscular atrophy perceive and experience healthcare, transition and well-being.

Authors:  Hamish W Y Wan; Kate A Carey; Arlene D'Silva; Nadine A Kasparian; Michelle A Farrar
Journal:  Orphanet J Rare Dis       Date:  2019-04-02       Impact factor: 4.123

5.  What's in a Name? Parents' and Healthcare Professionals' Preferred Terminology for Pathogenic Variants in Childhood Cancer Predisposition Genes.

Authors:  Jacqueline D Hunter; Eden G Robertson; Kate Hetherington; David S Ziegler; Glenn M Marshall; Judy Kirk; Jonathan M Marron; Avram E Denburg; Kristine Barlow-Stewart; Meera Warby; Katherine M Tucker; Brittany M Lee; Tracey A O'Brien; Claire E Wakefield
Journal:  J Pers Med       Date:  2022-08-18

6.  Scleroderma Patient-centered Intervention Network-Scleroderma Support group Leader EDucation (SPIN-SSLED) program: non-randomised feasibility trial.

Authors:  Brett D Thombs; Laura Dyas; Mia Pépin; Kylene Aguila; Marie-Eve Carrier; Lydia Tao; Sami Harb; Vanessa L Malcarne; Ghassan El-Baalbaki; Sandra Peláez; Maureen Sauve; Marie Hudson; Robert W Platt
Journal:  BMJ Open       Date:  2019-11-11       Impact factor: 2.692

7.  Rehabilitation management in two siblings with Von Hippel-Lindau syndrome: A case series.

Authors:  Paraskevi Tsingeli; Maria Christina Papadatou; Despoina Psillaki; Vasileios Tragoulias; Nikolaos Groumas; Yannis Dionyssiotis
Journal:  J Musculoskelet Neuronal Interact       Date:  2021-06-01       Impact factor: 2.041

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.